NCT02181153View on ClinicalTrials.gov

Genetic, Serological Fecal and Clinical Markers in Siblings of Children With Inflammatory Bowel Disease

NACompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

December 31, 2015

Study Completion Date

May 31, 2016

Conditions
Inflammatory Bowel Disease
Interventions
OTHER

sample blood and fecal collection

Blood and fecal samples will be collected at the day of enrolment

Trial Locations (1)

00161

Department of Pediatrics, Sapienza University of Rome, Rome

All Listed Sponsors
lead

University of Roma La Sapienza

OTHER

NCT02181153 - Genetic, Serological Fecal and Clinical Markers in Siblings of Children With Inflammatory Bowel Disease | Biotech Hunter | Biotech Hunter